The ad goes on to tout Hims & Hers' weight loss drugs as less expensive alternatives to medications like Ozempic and Wegovy, ...

While compounding drugs isn’t a new practice, due to the soaring demand for these weight loss drugs, it’s now a mainstream phenomenon. Semaglutide has been on the market for 20 years ...

A telehealth company partnered with a pharmacy that lacked a required license, raising doubts about the safety and efficacy ...

On Super Bowl Sunday, many tuning into the big game saw a controversial ad from the telehealth company Hims & Hers. The ...

Semaglutide — the active ingredient in the brand-name meds Ozempic, Wegovy, and Rybelsus — treats type 2 diabetes and obesity ...

Investors could be overestimating the contribution of Hims & Hers' compounded GLP-1 medications to its top line. Read why I ...

The “Check Before You Inject” ad goes on to note that some vials of compounded semaglutide “have been found to contain ...

Not all weight loss programs are made equal—to reach a healthy, sustainable weight, personalized programs offer the best ...

A recent study found that over a third of websites selling compounded diabetes and weight loss medications, such as Ozempic ...

For years, people taking Ozempic or other drugs in the same class for diabetes and weight loss have noticed the medicines don ...

As demand remains high for GLP-1 drugs, primary care physicians are concerned about the risks of patients using third-party ...